FILTER
FILTERED ARTICLE RESULTS
Peru’s Precious Metals: The Challenge of Keeping Volumes Up
July 06, 2018
Peru’s main gold mines are maturing, and production will increasingly come from medium-sized operations.
Copper: Closing the Gap with Chile
June 13, 2018
Peru strengthened its copper output in 2017, reaching 2.45 million tonnes.
Engineering and Construction
May 07, 2018
Providers eagerly await the transition from the studies and the early works to the execution of multi-billion dollar projects.
Peru: Exploration Gains Momentum
April 04, 2018
Juniors are back to life and the Andean country offers enormous potential for them.
Stepping Out of the Political Shadow
March 05, 2018
Peru's recent instability is not stopping mining investment.
Mineral Production in Peru
August 18, 2017
Peru's copper output reached 2.35 million metric tons in 2016.
Engineering: The 'Sponge' Factor
May 24, 2017
After significant downsizing and diversification, the mining-related workload will increase again for consultancy companies.
The Junior Segment: Picking Up
April 28, 2017
After years of very low market conditions in Peru, it is refreshing to see project developers and explorers coming back to life.
Production and Exploration Overview
April 03, 2017
New production caused Peru’s copper output to increase 70% between 2014 and 2016 assuring the nation's place as the second global producer. GBR looks at Peru’s growing production of metals and minerals.
Peru's Mining Sector: Rethinking the Future
March 01, 2017
As the industry becomes more dynamic globally, new strategies are required to avoid fresh growing pains
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
